SunOpta Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
SunOpta Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 | 2023-12-30 | 2023-09-30 | 2023-07-01 | 2023-04-01 | 2022-12-31 | 2022-10-01 | 2022-07-02 | 2022-04-02 | 2021-04-03 | 2021-01-02 | 2020-09-26 | 2020-06-27 | 2020-03-28 | 2019-12-28 | 2019-09-28 | 2018-06-30 | 2018-03-31 | 2005-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash provided by | |||||||||||||||||||||||
operating activities | |||||||||||||||||||||||
net earnings | 4,811,000 | 2,420,000 | 1,377,000 | -2,536,000 | 4,220,000 | 1,672,000 | 77,227,000 | -486,000 | -2,570,000 | 3,347,000 | |||||||||||||
net income from discontinued operations | |||||||||||||||||||||||
earnings from continuing operations | 4,811,000 | -3,781,000 | 3,837,000 | 1,377,000 | 1,844,000 | 654,000 | 1,672,000 | ||||||||||||||||
items not affecting cash: | |||||||||||||||||||||||
depreciation and amortization | 9,726,000 | 9,492,000 | 9,319,000 | 9,110,000 | 8,576,000 | 23,056,000 | -2,804,000 | 789,000 | 9,998,000 | 27,943,000 | 358,000 | -41,000 | 9,413,000 | 8,043,000 | 21,639,000 | -82,000 | -171,000 | 8,922,000 | 25,435,000 | 331,000 | 48,000 | 8,141,000 | |
amortization of debt issuance costs | 249,000 | 228,000 | 229,000 | 228,000 | 229,000 | 1,100,000 | -90,000 | -19,000 | 407,000 | 1,188,000 | 17,000 | 21,000 | 375,000 | 285,000 | 3,059,000 | -46,000 | 126,000 | 939,000 | 2,038,000 | -1,000 | -8,000 | 608,000 | |
stock-based compensation | 1,543,000 | 921,000 | 2,527,000 | 2,443,000 | 5,299,000 | 8,710,000 | 1,039,000 | -1,863,000 | 3,892,000 | 9,738,000 | 122,000 | 2,341,000 | 1,629,000 | 3,973,000 | 8,140,000 | 1,604,000 | -515,000 | 2,447,000 | 4,927,000 | -440,000 | -67,000 | 2,171,000 | |
gain on sale of smoothie bowls product line | |||||||||||||||||||||||
other | 603,000 | 1,523,000 | 111,000 | -178,000 | 178,000 | 388,000 | 1,000 | 886,000 | |||||||||||||||
changes in operating assets and liabilities, net of divestitures | 6,049,000 | ||||||||||||||||||||||
net cash from operating activities of continuing operations | 22,281,000 | 33,118,000 | 17,208,000 | -5,389,000 | 7,402,000 | 12,011,000 | 3,867,000 | 40,602,000 | 22,427,000 | -17,997,000 | 15,543,000 | ||||||||||||
net cash from operating activities of discontinued operations | -5,252,000 | ||||||||||||||||||||||
net cash from operating activities | 22,281,000 | 33,118,000 | 5,269,000 | ||||||||||||||||||||
capex | 0 | 0 | 0 | ||||||||||||||||||||
free cash flows | 22,281,000 | 33,118,000 | 5,269,000 | ||||||||||||||||||||
investing activities | |||||||||||||||||||||||
additions to property, plant and equipment | |||||||||||||||||||||||
addition to intangible assets | |||||||||||||||||||||||
proceeds from sale of smoothie bowls product line | 0 | ||||||||||||||||||||||
net cash from investing activities of continuing operations | |||||||||||||||||||||||
net cash from investing activities of discontinued operations | 0 | 0 | 0 | 6,300,000 | |||||||||||||||||||
net cash from investing activities | 2,088,000 | ||||||||||||||||||||||
financing activities | |||||||||||||||||||||||
increase in borrowings under revolving credit facilities | -16,163,000 | -8,000,000 | 26,100,000 | 250,000 | 8,812,000 | ||||||||||||||||||
repayment of long-term debt | |||||||||||||||||||||||
borrowings of long-term debt | 8,485,000 | 301,000 | 199,348,000 | -133,000 | -18,053,000 | 18,693,000 | 57,813,000 | 14,888,000 | -4,691,000 | 22,897,000 | 486,000 | ||||||||||||
proceeds from notes payable | 41,750,000 | 30,392,000 | 28,793,000 | 37,053,000 | 33,424,000 | 59,536,000 | 18,074,000 | 13,771,000 | 10,662,000 | ||||||||||||||
repayment of notes payable | |||||||||||||||||||||||
proceeds from the exercise of stock options and employee share purchases | 368,000 | 1,016,000 | 170,000 | 435,000 | 314,000 | 1,627,000 | -32,000 | -2,000 | 289,000 | 1,016,000 | 271,000 | 91,000 | 250,000 | 2,640,000 | 1,184,000 | 101,000 | 149,000 | ||||||
payment of withholding taxes on stock-based awards | |||||||||||||||||||||||
payment of cash dividends on preferred stock | |||||||||||||||||||||||
net cash from financing activities of continuing operations | 21,821,000 | 44,860,000 | -41,055,000 | 33,653,000 | 9,243,000 | 29,045,000 | |||||||||||||||||
increase in cash, cash equivalents and restricted cash in the period | 729,000 | -1,624,000 | -781,000 | 864,000 | 1,799,000 | ||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of the period | 9,012,000 | 0 | 0 | 8,754,000 | |||||||||||||||||||
cash, cash equivalents and restricted cash, end of the period | 9,741,000 | -781,000 | 864,000 | 10,553,000 | |||||||||||||||||||
non-cash investing and financing activities | |||||||||||||||||||||||
net income | |||||||||||||||||||||||
net earnings from continuing operations | |||||||||||||||||||||||
deferred income taxes | 3,696,000 | -8,546,000 | 2,048,000 | 80,000 | 837,000 | 5,260,000 | -665,000 | 2,698,000 | 260,000 | 153,000 | |||||||||||||
gain on sale of property, plant and equipment | |||||||||||||||||||||||
loss on extinguishment of debt | |||||||||||||||||||||||
proceeds from sale of property, plant and equipment | 4,182,000 | ||||||||||||||||||||||
cash settlement of foreign currency forward contract | |||||||||||||||||||||||
repayment of asset-based credit facilities | |||||||||||||||||||||||
payment of debt issuance costs | |||||||||||||||||||||||
payment of common share issuance costs | |||||||||||||||||||||||
payment of preferred stock issuance costs | |||||||||||||||||||||||
net cash from financing activities of discontinued operations | |||||||||||||||||||||||
net cash from financing activities | 44,860,000 | -41,055,000 | 33,653,000 | 9,243,000 | 28,845,000 | ||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of the year | |||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of the year | |||||||||||||||||||||||
income from continuing operations | |||||||||||||||||||||||
payment of share issuance costs | |||||||||||||||||||||||
sunopta inc. | 7,000 | ||||||||||||||||||||||
proceeds received from sale of smoothie bowls product line | 0 | 3,336,000 | |||||||||||||||||||||
earnings from discontinued operations | -4,380,000 | 3,566,000 | |||||||||||||||||||||
income from discontinued operations | |||||||||||||||||||||||
impairment of long-lived assets | -269,000 | 339,000 | |||||||||||||||||||||
additions to intangible assets | |||||||||||||||||||||||
increase in cash, cash equivalents and restricted cash during the year | |||||||||||||||||||||||
cash and cash equivalents, beginning of the year | |||||||||||||||||||||||
cash and cash equivalents, beginning of the period | |||||||||||||||||||||||
changes in operating assets and liabilities | 24,455,000 | -25,733,000 | 3,281,000 | ||||||||||||||||||||
proceeds from sale of sunflower business | 385,000 | ||||||||||||||||||||||
increase in cash and cash equivalents in the period | -160,000 | 231,000 | -210,000 | 268,000 | 503,000 | 1,172,000 | |||||||||||||||||
cash and cash equivalent, beginning of the period | 231,000 | 679,000 | 58,000 | 268,000 | 227,000 | 251,000 | |||||||||||||||||
cash and cash equivalents, end of the period | 71,000 | 910,000 | -94,000 | 58,000 | 495,000 | 754,000 | |||||||||||||||||
loss on sale of sunflower business | |||||||||||||||||||||||
gain on sale of frozen fruit processing facility | |||||||||||||||||||||||
loss on foreign currency forward contract | |||||||||||||||||||||||
loss on retirement of debt | |||||||||||||||||||||||
changes in operating assets and liabilities, net of sunflower business | |||||||||||||||||||||||
net proceeds from sale of sunflower business | |||||||||||||||||||||||
repayment of long-term debt, including premium paid | |||||||||||||||||||||||
proceeds on issuance of preferred stock, net of issuance costs | |||||||||||||||||||||||
increase in cash and cash equivalents during the year | |||||||||||||||||||||||
cash and cash equivalents of discontinued operations: | |||||||||||||||||||||||
balance at the beginning of the year | |||||||||||||||||||||||
foreign exchange gain on cash and cash equivalents | |||||||||||||||||||||||
less: balance at the end of year | |||||||||||||||||||||||
cash and cash equivalents, end of the year | |||||||||||||||||||||||
loss on classification of sunflower business as held for sale | |||||||||||||||||||||||
proceeds from sale of assets | 1,774,000 | 1,204,000 | 1,350,000 | -670,000 | 700,000 | ||||||||||||||||||
increase under revolving credit facilities | 41,585,000 | ||||||||||||||||||||||
gain on sale of business | 908,000 | ||||||||||||||||||||||
changes in operating assets and liabilities, net of businesses sold | |||||||||||||||||||||||
net proceeds from sale of businesses | |||||||||||||||||||||||
decrease in cash and cash equivalents during the year | |||||||||||||||||||||||
purchases of property, plant and equipment | |||||||||||||||||||||||
balance at beginning of period | |||||||||||||||||||||||
foreign exchange loss on cash and cash equivalents | |||||||||||||||||||||||
less: balance at end of period | |||||||||||||||||||||||
goodwill impairment | |||||||||||||||||||||||
reserve for notes receivable | |||||||||||||||||||||||
proceeds on issuance of series b-1 preferred stock, net of issuance costs | |||||||||||||||||||||||
unrealized loss on derivative contracts | 556,000 | ||||||||||||||||||||||
gain on settlement of contingent consideration | |||||||||||||||||||||||
obligation | |||||||||||||||||||||||
changes in non-cash working capital, net of businesses | |||||||||||||||||||||||
acquired or sold | |||||||||||||||||||||||
net cash flows from operating activities | 17,496,000 | -32,084,000 | 34,749,000 | ||||||||||||||||||||
net proceeds from sale of business | |||||||||||||||||||||||
acquisition of business, net of cash acquired | |||||||||||||||||||||||
net cash flows from investing activities | |||||||||||||||||||||||
increase under line of credit facilities | -38,764,000 | 49,576,000 | 309,000 | ||||||||||||||||||||
borrowings under long-term debt | 155,000 | 2,665,000 | 541,000 | ||||||||||||||||||||
payment of contingent consideration | |||||||||||||||||||||||
dividend paid by subsidiary to non-controlling interest | |||||||||||||||||||||||
net cash flows from financing activities | -37,968,000 | ||||||||||||||||||||||
foreign exchange gain on cash held in a foreign currency | 3,000 | 29,000 | |||||||||||||||||||||
decrease in cash and cash equivalents in the period | |||||||||||||||||||||||
cash and cash equivalents - beginning of the period | -1,045,000 | 1,172,000 | 1,498,000 | -3,485,000 | -304,000 | 3,228,000 | |||||||||||||||||
cash and cash equivalents - end of the period | -687,000 | -1,045,000 | 2,670,000 | -321,000 | -837,000 | 2,924,000 | |||||||||||||||||
unrealized gain on derivative contracts | |||||||||||||||||||||||
gain on settlement of contingent consideration obligation | |||||||||||||||||||||||
changes in non-cash working capital, net of businesses acquired or sold | |||||||||||||||||||||||
proceeds from the exercise of stock options and employee purchases | |||||||||||||||||||||||
changes in non-cash working capital, net of business sold | 20,654,000 | ||||||||||||||||||||||
decrease under line of credit facilities | |||||||||||||||||||||||
payment of cash dividends on series a preferred stock | |||||||||||||||||||||||
foreign exchange loss on cash held in a foreign currency | |||||||||||||||||||||||
unrealized gain on derivative instruments | |||||||||||||||||||||||
fair value of contingent consideration | |||||||||||||||||||||||
acquisition of non-controlling interests | |||||||||||||||||||||||
dividends paid by subsidiary to non-controlling interest | |||||||||||||||||||||||
cash and cash equivalents - beginning of the year | |||||||||||||||||||||||
cash and cash equivalents - end of the year | |||||||||||||||||||||||
net cash flows from operations | 7,506,000 | ||||||||||||||||||||||
proceeds from the exercise of stock options and employee | |||||||||||||||||||||||
share purchases | 127,000 | ||||||||||||||||||||||
sunopta inc | |||||||||||||||||||||||
non-cash financing activity | |||||||||||||||||||||||
accrued cash dividends on series a preferred stock | |||||||||||||||||||||||
cash from | |||||||||||||||||||||||
income from discontinued operations attributable to sunopta inc. | |||||||||||||||||||||||
acquisition accounting adjustment on inventory sold | |||||||||||||||||||||||
changes in non-cash working capital | 2,889,000 | ||||||||||||||||||||||
net cash flows from operating activities - continuing operations | |||||||||||||||||||||||
net cash flows from operating activities - discontinued operations | |||||||||||||||||||||||
payments received on note from sale of business | |||||||||||||||||||||||
net cash flows from investing activities - continuing operations | |||||||||||||||||||||||
net cash flows from investing activities - discontinued operations | |||||||||||||||||||||||
repayment of line of credit facilities | |||||||||||||||||||||||
issuance of series a preferred stock | |||||||||||||||||||||||
net cash flows from financing activities - continuing operations | |||||||||||||||||||||||
net cash flows from financing activities - discontinued operations | |||||||||||||||||||||||
discontinued operations cash activity included above: | |||||||||||||||||||||||
add: balance included at beginning of year | |||||||||||||||||||||||
less: balance included at end of year | |||||||||||||||||||||||
proceeds from the exercise of stock options and employee share purchases, net of withholding taxes paid | |||||||||||||||||||||||
unrealized loss on derivative commodity contracts | 1,521,000 | ||||||||||||||||||||||
loss | |||||||||||||||||||||||
amortization and write-off of debt issuance costs | |||||||||||||||||||||||
net cash flows from operations - continuing operations | |||||||||||||||||||||||
net cash flows from operations - discontinued operations | |||||||||||||||||||||||
add: balance included at beginning of period | |||||||||||||||||||||||
less: balance included at end of period | |||||||||||||||||||||||
earnings | |||||||||||||||||||||||
impairment loss on investment | |||||||||||||||||||||||
changes in non-cash working capital, net of businesses acquired | |||||||||||||||||||||||
acquisitions of businesses, net of cash acquired | |||||||||||||||||||||||
decrease in restricted cash | |||||||||||||||||||||||
financing costs | |||||||||||||||||||||||
proceeds from the issuance of common shares | |||||||||||||||||||||||
supplemental cash flow information | |||||||||||||||||||||||
net earnings for the period | 6,605,000 | ||||||||||||||||||||||
items not affecting cash | |||||||||||||||||||||||
amortization | 1,751,000 | ||||||||||||||||||||||
minority interest | 173,000 | ||||||||||||||||||||||
gain on disposition on property, plant and equipment | |||||||||||||||||||||||
acquisition of companies, net of cash acquired | |||||||||||||||||||||||
proceeds from note receivable | |||||||||||||||||||||||
increase in bank indebtedness | 6,815,000 | ||||||||||||||||||||||
borrowings under term debt facilities | |||||||||||||||||||||||
repayment of term debt facilities | |||||||||||||||||||||||
proceeds from the issuance of common shares, net of issuance costs | 209,000 | ||||||||||||||||||||||
increase in cash and cash equivalents during the period | 2,562,000 | ||||||||||||||||||||||
cash and cash equivalents – beginning of the period | 8,081,000 | ||||||||||||||||||||||
cash and cash equivalents – end of the period | 10,643,000 | ||||||||||||||||||||||
proceeds from sale of property, property and equipment | 19,000 | ||||||||||||||||||||||
borrowings under term debt | |||||||||||||||||||||||
repayment of term debt | |||||||||||||||||||||||
repayment of deferred purchase consideration | |||||||||||||||||||||||
decrease in cash and cash equivalents during the period | |||||||||||||||||||||||
see note 10 for supplemental cash flow information | |||||||||||||||||||||||
dilution gain | |||||||||||||||||||||||
common shares granted to opta minerals employees | 234,000 | ||||||||||||||||||||||
purchase of property, plant and equipment | |||||||||||||||||||||||
proceeds from opta minerals inc. share issuance | 14,290,000 | ||||||||||||||||||||||
see note 8 for supplemental cash flow information |
We provide you with 20 years of cash flow statements for SunOpta stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SunOpta stock. Explore the full financial landscape of SunOpta stock with our expertly curated income statements.
The information provided in this report about SunOpta stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.